求助文献全篇下载

baby00000003

Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement$ L8 C, V+ ?9 t9 s3 [
M. Ueda, Y. Yamada, R. Ozawa, Y. Okazaki# P+ q. `* }/ e3 X$ T
DOI: http://dx.doi.org/10.1016/j.prosdent.2005.05.019
" w* R, {7 y2 P  e1 A# a% z" g% ?1 ?- E* c" Y5 y7 D. g/ ~. D
感谢各位老师的无私援助～

farui

Noteworthy Abstracts of the Current Literature& O, u: N$ p4 Y) `6 T. X
Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement
+ s1 q) X+ C+ [4 Z4 V- ~* |" T
7 k' A# y6 [3 _# b% ]8 O    M. Ueda, Y. Yamada, R. Ozawa, Y. Okazaki
6 R5 i# U) R/ @( d# `1 m0 e8 k
Show more0 Y+ q- ?" P8 \, l# }$ x

% O; ^% g8 s- V        doi:10.1016/j.prosdent.2005.05.019
7 A; r4 B7 H/ R) ?; q    Get rights and content
9 U4 o* c! r7 k
5 ]- I% O8 \3 k( n* XThis clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height. All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success.—Reprinted with permission of Quintessence Publishing.
; j  W$ H) Z1 w% {$ ^+ U1 Z0 z
9 i2 q4 r$ M( A4 d5 w整个PDF就这一点内容

baby00000003

回复 farui 的帖子
" {) D+ p5 F) U; F, Z' w+ m  L. Y, r
那必然不是呀～